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ABSTRACT
The Role of the Transcriptional Antiterminator RfaH in Lipopolysaccharide
Synthesis, Antimicrobial Peptide Resistance, and Virulence of
Yersinia pseudotuberculosis and Yersinia pestis
Jared Michael Hoffman
Department of Microbiology and Molecular Biology, BYU
Master of Science
RfaH is a unique bacterial protein that enhances transcription of a select group of long operons in
many Gram-negative bacteria. Operons regulated by RfaH possess an upstream operon polarity
suppressor sequence, which recruits the RfaH protein to the RNA polymerase during
transcription of genes, most of which are involved in the synthesis of cell-surface features. These
include synthesis of the lipopolysaccharide (LPS) core and O-antigen in Salmonella and
Escherichia coli, as well as F-plasmid conjugation pilus and capsule in E. coli. LPS is an
important virulence factor in many Gram-negative bacteria, and protects Y. pseudotuberculosis
against host antimicrobial chemokines. Recently published high-throughput transposon mutant
screens have also suggested a role for RfaH in the ability of Y. pseudotuberculosis to colonize
mice. However, the role of RfaH in Y. pseudotuberculosis and its descendent Yersinia pestis has
not been carefully examined. In these studies we investigated the effect RfaH has on the structure
of the LPS in both species at different temperatures. We also identified LPS-synthesis related
genes that are regulated by RfaH. We determined the effect of RfaH on bacterial resistance to
host defense peptides, and the ability of Y. pseudotuberculosis to colonize mice. We found that
the loss of the rfaH gene had different effects in Y. pseudotuberculosis and Y. pestis. Loss of
rfaH caused a truncation in the core region in Y. pseudotuberculosis strain IP32953 at both 21°C
and 37°C, but only at 37°C in Y. pestis strain KIM6+. Similarly, we found that transcription of
individual genes that are predicted to function in core or O-antigen synthesis were
downregulated in the rfaH mutant strains in both species, but the impact of rfaH deletion was
greater in Y. pseudotuberculosis. When tested for their ability to survive in the presence of
antimicrobial peptides, the Y. pseudotuberculosis rfaH deficient bacteria were much more
susceptible than wild-type to killing by polymyxin and by the antimicrobial chemokine CCL28.
However, the Y. pestis rfaH mutant strain was equally susceptible to CCL28 as the wild-type
strain. Infection of mice with Y. pseudotuberculosis show that rfaH deficient bacteria were able
to survive as effectively as the wild-type following oral or intravenous inoculation, with or
without the pYV virulence plasmid. Overall, our results show that while RfaH controls LPS gene
expression in both Y. pseudotuberculosis and Y. pestis, its impact is much greater in Y.
pseudotuberculosis. Furthermore, although loss of rfaH greatly reduces the ability of Y.
pseudotuberculosis to resist antimicrobial peptides, it is not required for virulence in this species.
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INTRODUCTION
Yersinia
The genus Yersinia is a member of the Enterobacteriaceae family. There are eleven
species, three of which are pathogenic to humans: Yersinia pestis, Yersinia pseudotuberculosis,
and Yersinia enterocolitica [1]. These studies focus on Y. pestis and Y. pseudotuberculosis,
which are extremely closely related and are a fascinating model system for investigating the
evolution of bacterial pathogens. Y. pestis is a Gram-negative, facultatively anaerobic, nonmotile
coccobacillus. It is the causative agent of plague which has been responsible for three pandemics
and the death of two hundred million in recorded history [1]. The strains of Y. pestis are
subdivided into four groups based on their ability to ferment sugars and reduce nitrate: Antiqua,
Medievalis, Pestoides, and Orientalis [2]. Y. pestis uses rodents as its reservoir and can be
transmitted to humans through a flea bite, which can result in bubonic or septicemic plague [3].
Y. pestis can also be spread through inhalation and cause pneumonic plague [4].
Y. pseudotuberculosis is a food borne pathogen that causes self-limiting gastroenteritis
[5]. Yersinia pseudotuberculosis was first discovered in 1883 from guinea pigs that had
tuberculosis like lesions [6]. It has diverse animal reservoirs such as in brown hares and sheep
located in many different countries. Transmission to humans is uncommon and can occur
sporadically or in outbreaks of contaminated food [6, 7]. In Russia, Y. pseudotuberculosis has
been linked to outbreaks which cause Far-East scarlet-like fever which is characterized by severe
systemic inflammatory symptoms [8]. There are 21 different serotype variants of Y.
pseudotuberculosis that are characterized by the structure of the lipopolysaccharide O-antigen
[9].
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As an enteric pathogen, Yersinia pseudotuberculosis enters the human body through
contaminated food or water. Once it passes through the stomach, Y. pseudotuberculosis travels to
the ileum of the small intestine and translocates through lymphoid associated tissues known as
Peyer’s patches [10]. The Peyer’s patches are specialized intestinal areas that contain specialized
M cells which bind and transport luminal antigens in order to commence an adaptive immune
response [11]. Normally M cells phagocytose antigens and pass them to local antigen-presenting
cells such as macrophages and dendritic cells. These cells present them to local lymphocytes or
bring them to the mesenteric lymph nodes [5, 12]. Y. pseudotuberculosis uses a chromosomallyencoded protein called invasin to bind to β1-integrins on mammalian cells to be taken up by the
M cells [10]. Approximately 24 hours of after an oral infection, Y. pseudotuberculosis can be
found within the mesenteric lymph nodes and after 48 - 72 hours it appears in the spleen and
liver [5]. Colonization of the local lymphatic tissue can lead to dissemination of Y.
pseudotuberculosis into the blood stream via lymph drainage in the thoracic duct [5].
The three pathogenic strains of Yersinia in humans contain a 70 kb virulence plasmid
called pYV (or pCD1 in Y. pestis) [13]. This virulence plasmid encodes a type III secretion
system which Yersinia uses to inject Yersinia outer proteins (Yops) to survive and replicate
within lymphoid tissue [14]. The effector Yops proteins have a wide variety of functions
including counteracting proinflammatory cytokine production and preventing phagocytosis [15,
16]. A Y. pseudotuberculosis mutant strain lacking several of the Yops proteins was unable to
colonize the gastrointestinal tract and Peyer’s patches in an oral infection [17]. However, it was
subsequently discovered that Y. pseudotuberculosis lacking the plasmid grow just as well in the
mesenteric lymph nodes as those that had the plasmid following oral infection [18]. The pYV
plasmid-negative (P-) Y. pseudotuberculosis reside extracellularly in B and T cells in the cortex
2

and paracortex of the mesenteric lymph nodes. These areas offer protection against phagocytic
cells. The P- strains also caused a milder inflammatory response [19]. In order to find
chromosomal virulence factors that allow the bacteria to survive in internal organs in the absence
of the pYV virulence factors, a collection of transposon mutants of P- strains of Y.
pseudotuberculosis was passaged through mice. During oral infection, only a few bacteria among
the thousands that enter the intestine are able to pass through the intestinal barrier to colonize
deeper tissues. These few founding colonizers then go on to replicate to great numbers. In order
to bypass the severe bottleneck presented by the intestinal mucosal tissue, the researchers
infected mice intravenously with pools of mutants and then isolated surviving bacteria from the
liver. This allowed them to find chromosomal virulence factors based on the inability to detect
many P- transposon mutants in these organs. Many of the mutants of that failed to survive in liver
had insertions in genes involved in lipopolysaccharide synthesis, including the transcriptional
antiterminator RfaH [18] Mutants with insertion in rfaH were estimated to have a 100,000- fold
decrease in their ability to survive in the liver.
Evolutionary relationship between Y. pestis and Y. pseudotuberculosis
Comparative genomic analysis of genes in Y. pestis show that it is a clone that evolved
from Y. pseudotuberculosis 1,500-20,000 years ago [20]. Y. enterocolitica represents a distinct
evolutionary lineage [1]. Phylogenetic analysis using single nucleotide polymorphisms (SNPs)
from 133 strains of Y. pestis has shown that the Y. pseudotuberculosis genomes share the same
SNPs as Y. pestis and from this sequential mutations in the evolution of Y. pestis can be defined
[21]. Recent studies sequenced hundreds of Y. pestis genomes and found that Y. pestis evolved
from Y. pseudotuberculosis in China and spread to West Asia and Africa [22]. The extremely
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close genetic relationship and established ancestry between these species of bacteria provide an
excellent model for the study of pathogen evolution.
While the genomes of Y. pestis and Y. pseudotuberculosis are very similar, there are
many changes that occurred in the evolution of Y. pestis that allowed it to take advantage of a
completely different route of infection. Y. pestis has 32 chromosomal genes that are not present
in Y. pseudotuberculosis, as well as two Y. pestis specific plasmids. One of the important genes
found on the Y. pestis specific plasmids is ymt, which encodes the phospholipase D enzyme that
allows Y. pestis to infect the midgut of fleas [23]. Y. pestis has 317 pseudogenes that have been
inactivated by frameshift mutations or insertion sequences, but which are functional in Y.
pseudotuberculosis [24]. One such gene that has been inactivated in Y. pestis is the ureE gene.
This gene encodes urease activity which while useful to an enteric pathogen is orally toxic to
fleas [25]. Five inactivated genes are located in the O-antigen gene cluster in Y. pestis. The
inactivation of these genes prevent the synthesis of the O-antigen in Y. pestis which is necessary
for the proper function of the Pla protease. The Pla protease is another plasmid-encoded protein
necessary for activation of human plasminogen and is not found in Y. pseudotuberculosis [26]. Y.
pseudotuberculosis has a fully functional Rcs regulatory system, which negatively regulates
extracellular polysaccharide and biofilm formation, but this system has been inactivated in Y.
pestis [27]. The loss of these genes was essential for enhanced biofilm formation and efficient
transmission of Y. pestis from fleas to mammals. Thus, mutations in regulatory pathways
affecting cell envelope structures including LPS and capsule polysaccharides has contributed to
vastly different lifestyles and pathogenic potential among these two closely related species.
Yersinia lipopolysaccharide
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Y. pestis and Y. pseudotuberculosis are Gram-negative bacteria and as such they possess
lipopolysaccharide (LPS) structures in the outer leaflet of their outer membranes. LPS serves as a
virulence factor as it provides resistance from antibiotics, complement, and other host defenses
[28]. The LPS is composed of three major parts: the lipid A, core oligosaccharide, and Oantigen.
Lipid A, also known as endotoxin, causes an excessive release of pro-inflammatory
cytokines by host macrophages [28]. Lipid A is absolutely required for growth of the bacteria
[29]. It is composed of biphosporylated glucosamine residues that have four or six acyl chains
attached which allow it to embed in the outer leaflet of the outer membrane [30]. In Yersinia, the
number of acyl chains changes depending on the growth temperature of the bacteria. At 21°C Y.
pestis and Y. pseudotuberculosis produce hexaacylated lipid A and tetraacylated lipid A at 37°C
[31]. Reducing the number of acyl chains at 37°C results in a less immunostimulatory LPS and
likely helps Y. pestis to avoid activation of the immune system [31].
The core oligosaccharide is attached to the lipid A and consists of the inner and outer
core. The inner core is made up of five conserved saccharide moieties: 2 3-Deoxy-ᴅ-manno-oct2-ulosonic acid (Kdo) and 3 ʟ-glycero-ᴅ-manno-Heptoses (ʟ-ᴅ-Heptose) residues [28]. Y. pestis
also has an additional glucose residue bound to one of the heptose residues (Figure 1). As with
the lipid A portion, the inner core of Y. pestis changes in response to a decrease in temperature.
At 21°C, one of the Kdo residues is replaced with a ᴅ-glycero-ᴅ-talo-oct-ulosonic acid (Ko)
residue. Y. pestis also lacks the typical outer core found in other Gram-negative bacteria, which
includes an additional four residues of glucose and galactose, and possess an additional ᴅ-ᴅHeptose residue or ᴅ-galactose residue (at 21°C) [28].
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The O-antigen is a repeating polysaccharide chain that extends out from the core
oligosaccharide [32]. Y. pestis does not produce O-antigen due to frameshift mutations in the
ddhB, wbyI, wzy, gmd, and fcl genes which are located in the ddhD-wzz gene cluster [9]. Y.
pseudotuberculosis produces diverse O-antigens, which forms the basis for serotyping of Y.
pseudotuberculosis strains [33]. There are 21 known serotypes of Y. pseudotuberculosis. Based
on phylogenetic analysis of the O-antigen gene cluster, Y. pestis is thought to have evolved from
a serotype O:1b ancestor [9].
Each portion of the LPS plays a specific role in the defense of the bacteria against host
defense peptides. It has been shown previously that mutations in core LPS genes which result in
truncation of the LPS in Burkholderia cenocepacia decreased resistance to polymyxin B and
melittin [34]. When genes related to the synthesis of the O-antigen were knocked out in B.
cenocepacia, it did not increase susceptibility to polymyxin B [34]. Therefore, the core region
conferred resistance to antimicrobial peptides.
Lipopolysaccharide synthesis
Synthesis of LPS proceeds in distinct stages and locations in order to deliver the final
product in the outer membrane of the bacterial cell. The lipid A and Kdo regions are synthesized
in the cytoplasmic side of the inner membrane [29]. The first step in this process is the
attachment of fatty acids to oxygen and nitrogen residues within a UDP-GlcNAc (Nacetylglucosamine) molecule [35]. The enzyme WaaA then adds on the Kdo residues and
following this additional fatty acid chains can be added on to the oxygens of the carboxylic acid
groups [36].
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The core region is also synthesized in the cytoplasm by a series of enzymes as shown in
Figure 1. The first sugar ʟ,ᴅ-Heptose I is added to the Kdo residue by the enzyme WaaC. [37].
This sugar is synthesized from sedoheptulose-7-P in a series of steps requiring the HldD enzyme
(also known as GmhA) [38]. The genes waaE, waaF, waaL, waaQ, and wabC/D encode
glycosyltransferases. These enzymes add glucose, ʟ,ᴅ-Heptose II, GlcNAc, ʟ,ᴅ-Heptose III, and
ᴅ-ᴅ Heptose or galactose (WabC/WabD depending on the temperature) to assemble the core.
Once the core is completed, The MsbA flippase protein transports the completed lipid A and core
structure from the cytoplasmic to the periplasmic side of the inner membrane [39].
The O-antigen is synthesized by genes that are usually arranged in clusters or operons,
and in Yersinia they are found between the hemH and gsk genes [40]. Glycosyltransferase
enzymes encoded in this region synthesize heteropolymeric O-units in the cytoplasm, which are
transported to the periplasm via a Wzy-dependent process [37]. The O-antigen in Yersinia
pseudotuberculosis contains rare sugars synthesized from glucose-1-phosphate [40]. These are
known as 3,6-dideoxyhexose sugars and their synthesis requires the ddh genes. DdhA and DdhB
catalyze the reaction of glucose-1-phosphate to CDP-6-deoxy-ᴅ-xylo-4-hexulose. DdhC and
DdhD then interact to perform C-3 deoxygenation of CDP-6-deoxy-ᴅ-xylo-4-hexulose into CDP3,6-dideoxyhexoses [40]. The O-units are transported to the periplasmic space and are assembled
by Wzy and Wzz. Wzy is the O-antigen polymerase and Wzz determines the O-antigen chain
length [41]. Once completed, these are added to the lipid A + core on the periplasmic side of the
inner membrane by the ligase protein WaaL [37]. The Lpt (LptA to LptG) proteins are
responsible for transporting the completed LPS molecule from the inner membrane to the outer
membrane [42]. The LptB2CFG protein complex extracts the LPS from the inner membrane.
LptA, LptC, and LptD form a bridge to transport the LPS molecule from the inner membrane to
7

the outer membrane [43]. The LptDE outer membrane translocon has a barrel shape and inserts
the LPS molecule in the outer leaflet of the outer membrane [44].
Antimicrobial peptides
Antimicrobial peptides are in important part of the innate immune system. They are a
first line of defense against bacteria as they provide broad-spectrum antimicrobial activity [45].
Examples of antimicrobial peptides include defensins, cathelicidins, and histatins. Their primary
mechanism of action is to disrupt bacterial membranes [46]. Many antimicrobial peptides have a
cationic charge which gives them an affinity to negatively charged bacterial membranes [45].
Some peptides interact with the acyl chains of the lipid membrane and oligomerize to form an
aqueous pore. Some bacteria resist the activity of cationic antimicrobial peptides by modifying
their lipopolysaccharide in order to change the ionic charge of the membrane [47].
Antimicrobial chemokines
Chemokines are a class of small (8-12 kDa) chemotactic cytokines. The primary role of
these chemokines is to recruit immune cells to sites of infection. Recently it was discovered that
some of these chemokines may have antimicrobial effects upon bacteria, similar to the activity of
antimicrobial peptides such as defensins [48]. For example, CCL28, also known as mucosaeassociated epithelial chemokine, is an antimicrobial chemokine that binds to the chemokine
receptors CCR10 and CCR3 [49]. CCL28 is expressed abundantly in the mucosal in the trachea,
colon, salivary, and mammary glands. It is constitutively expressed in the epithelial cells of the
salivary glands and found in high concentrations in the saliva and milk. It exhibits broadspectrum antimicrobial activity against gram negative and gram positive bacteria [50]. CCL28
has been shown to have potent in vitro antimicrobial activity against organisms that cause
8

mastitis in dairy cattle, including Staphylococcus aureus and E. coli [51]. Although the exact
mechanism of killing is unknown, it is believed to function like the β-defensin antimicrobial
peptides by binding through electrostatic interactions and forming membrane pores. The
antimicrobial activity of CCL28, like many antimicrobial peptides, requires low osmolarity
solutions to exert its effects [52].
It has been shown that the LPS provides resistance to antimicrobial chemokines.
Modifications to the lipid A moiety by adding 4-amino-4-deoxy-L-arabinose can help to mask
the negative charge of the bacterial membrane and can provide resistance to CCL28 [53]. When
the LPS was truncated in response to a transposon insertion in the hldD gene it increased
susceptibility to CCL28 [54]. A previous study used transposon mutagenesis in Y.
pseudotuberculosis to identify genes that function in providing resistance to antimicrobial
chemokines CCL25 and CCL28 [55]. One of the genes that was identified in this screen which
decreased the resistance of Y. pseudotuberculosis to CCL28 was rfaH. A separate study found
that when the rfaH gene was deleted from Y. enterocolitica, it caused the bacteria became more
susceptible to polymyxin and detergent due to changes in the LPS [56].
Transcriptional antiterminator, RfaH
In bacteria, groups of functionally related genes are often organized into operons that are
regulated at the level of transcription [57]. Typically this involves repressors or activators that
bind to promoters and controls access of RNA polymerase (RNAP). Another method of
transcriptional regulation and modification of genes is through RNAP associated proteins that
function in transcriptional elongation. During transcription of long operons, the RNAP might
experience random or programmed pause events and without help, it may prematurely stop
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transcription of long operons [58]. To counteract pausing, the essential NusG protein may bind to
the RNAP after the σ factor disassociates. It functions to increase transcriptional processivity by
suppressing RNAP pausing, ensuring that all genes in an operon are transcribed [59].
The RfaH protein also functions as a transcriptional antiterminator and shares significant
structural similarity with NusG, but it acts as a different set of operons in the genome [57]. RfaH
was originally discovered as a component in the synthesis of the lipopolysaccharide in
Salmonella enterica serovar typhimurium [60]. Since this initial discovery, RfaH has been shown
to function in a wide array of cellular functions including: F-plasmid conjugation pilus [61],
haemolysis toxin [62], and the E. coli type II K15 capsule [63]. In E. coli rfaH mutants, it has
been shown that there is a minor decrease in transcription of genes proximal to the promoter of
RfaH-regulated operons, but the transcription of more distal genes was more severely reduced
resulting in transcriptional polarity [64]. Similar to NusG, the RfaH protein allows the RNAP to
bypass intrinsic terminator sites, DNA binding proteins, or DNA lesions and transcribe the entire
operon completely [65, 66]. Functional complementation studies also indicate that despite
disparate primary amino acid sequences, the function of RfaH is conserved throughout the
gamma-proteobacteria [67]. In addition to its role in transcriptional regulation, RfaH also has a
role in coupling transcription to translation, which is an important feature in bacteria. RfaH can
undergo a conformational change from a closed state to an open state while bound to the RNAP.
This open configuration facilitates translation by binding to the ribosome and is important for
translation activation of the operons regulated by RfaH [68].
The specificity of RfaH to certain genes depends upon a regulatory site called the operon
polarity suppressor (ops) [69]. The ops sequence is typically found within the 5’-proximal
transcribed sequence of operons under control by RfaH and they display high sequence
10

conservation among bacterial species with homologous operons (Figure 2) [67]. The common 8bp ops sequence motif is 5’ –GGCGGTAG – 3’ (reported as a longer 12-bp motif in some
studies: 5’-RGGCGGTAGYnT-3’) and when this sequence is deleted it results in reduced
expression of genes close to the promoter while distal gene expression is almost abolished [62,
70]. During transcription, the ops sequence causes the RNAP to pause briefly. The exposed nontemplate strand with the ops sequence interacts with the RNAP structure and recruits the RfaH
protein [71]. The RfaH protein then binds to β’ subunit clamp in the RNAP, which is the same
binding site as the σ initiation factor [72]. In rfaH mutant bacteria, the poor transcription of distal
genes can be restored by purified RfaH protein. When the ops is present in in vitro experiments,
the amount of RfaH required to restore the transcription of these genes is reduced [57]. The
requirement of the ops sequence has been abolished in vivo if the RfaH protein is overexpressed
[57].
Effects of RfaH in Gram-negative pathogens
RfaH has been found to function in the synthesis of many components of Gram-negative
bacteria, some of which have direct consequences in infection. For instance, the chuA gene in
uropathogenic E. coli strain 563 is regulated by RfaH. The ChuA protein is an outer membrane
protein that functions in hemin utilization and is important for iron acquisition in this pathogen
[73]. Without RfaH, mutants of this strain are less virulent in mice [74]. In a different strain of
extraintestinal pathogenic E. coli, rfaH has been shown to be required for fitness in the intestinal
niche. These researchers found that the fitness defect of rfaH mutants was comparable to deeprough LPS mutants [75].
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Similar attenuation was also observed in a rfaH mutant strain of pathogenic Salmonella
enterica serovar Typhimurium strain SL1344 in orogastric and intraperitoneal mouse infections.
One possible explanation for the defect is that the loss of rfaH increases susceptibility to
antimicrobial peptides, which is a key defense against Salmonella [76]. As a consequence of the
attenuation, the researchers also found that by infecting the mice first with the rfaH mutant they
could immunize and protect the mice from a second infection with the wild-type pathogenic
strain [77].
While the effect of RfaH on in vivo virulence in Yersinia has not been investigated, a
recent study showed that the loss of RfaH in Y. enterocolitica O:3 reduces expression of Oantigen and outer core gene clusters and causes truncation of the LPS [56]. These changes cause
the bacteria to become more susceptible to polymyxin and detergent, but also more resistant to
serum complement attack. The researchers found Y. enterocolitica RfaH has greater specificity
for binding because there were >10 candidate ops sequences adjacent to genes with other
functions but their activity was not regulated by RfaH. In Y. pseudotuberculosis serotype O3
strain YPIII, transposon insertions in rfaH reduced the ability of the bacteria to compete with
other mutants in the livers and spleens of mice following intravenous injection. The researchers
speculated that loss of O-antigen production in the rfaH mutants could be the reason for their
reduced fitness, since many predicted O-antigen mutants had the same phenotype. However, they
did not test whether rfaH mutants were defective following oral infection, nor did they
experimentally determine a mechanism for attenuation of rfaH transposon mutants. These
previous studies suggest that further experiments investigating the effect of RfaH on virulence of
Yersinia are warranted.
Experimental objectives
12

The accumulated evidence described above suggests that RfaH is likely required for
production of O-antigen and possibly core oligosaccharide in Y. pseudotuberculosis. However,
since Y. pestis fails to produce O-antigen, the role of RfaH in this species is difficult to predict.
Further, any truncation of the LPS resulting from the loss of RfaH is likely increase susceptibility
to antimicrobial peptides. Therefore, we hypothesized that a Y. pseudotuberculosis rfaH mutant
will exhibit decreased virulence in an in vivo mouse infection. If so, then RfaH could be an
attractive target for the development of antibacterial treatments, given its importance in a diverse
group of pathogens.
The first objective in these studies was to identify the role that the rfaH plays in in the
synthesis of the O-antigen and core oligosaccharide in Y. pseudotuberculosis serotype O:1b
IP32953 and in Y. pestis KIM6+. We determined changes in the LPS structure in the wild-type
and rfaH mutant strains using SDS-PAGE gel electrophoresis. We then sought to correlate the
changes in LPS structure with transcriptional changes in LPS synthesis genes by quantitative
RT-PCR in these strains. The second objective was to determine how resistance to host defense
peptides is impacted by the loss of rfaH. We performed in vitro binding and killing assays with
antimicrobial peptides and chemokines to quantify the differences between the wild-type and the
rfaH gene mutants. The third objective was to identify any changes in virulence between the
wild-type and rfaH mutant bacteria. We measured bacterial survival in mouse organs following
oral or intravenous inoculation of wild type or rfaH mutant Y. pseudotuberculosis in both
virulence plasmid P+ and P- strains.

13

MATERIALS AND METHODS
Bacterial strains and growth conditions
The two wild-type bacterial strains used in this study were Yersinia pestis KIM6+ and
Yersinia pseudotuberculosis serotype O:1b IP32953. Both virulent (P+) and non-virulent (P-)
strains of Yersinia pseudotuberculosis were used which indicates the presence of the Yersinia
virulence plasmid, pYV. Kanamycin (30 µg/mL) and chloramphenicol (10 µg/mL) were added
as necessary when working with mutant strains. The strains were grown up in Terrific Broth
(TB) at either 21°C or 37°C. Escherichia coli strains used were grown up in Luria Broth (LB) at
37°C.
Gene deletions and complements
The rfaH gene was deleted from both Y. pestis and Y. pseudotuberculosis using a suicide
plasmid, pRE112 (Figure 3) [78]. Primers were designed using Geneious (Biomatter Inc.,
Newark, New Jersey) to include 500 bp upstream and downstream homology of the rfaH gene in
both Y. pestis and Y. pseudotuberculosis. The forward primer contained a SacI restriction site and
the reverse primer contained a KpnI restriction site. The primers were ordered from SigmaAldrich (St. Louis, Missouri) and are shown in Table 1. A kanamycin resistance gene (KmR) was
amplified using polymerase chain reaction (PCR) which included 500-bp upstream and
downstream homology of the rfaH gene. The amplified product was purified using a DNA Clean
and Concentrator Kit (Zymo Research, Irvine, California). The purified PCR product and the
pRE112 plasmid were then cut using SacI and KpnI restriction enzymes (New England Biolabs,
Ipswitch, MA). They were ligated together using an Instant Sticky End ligase mix (New England
Biolabs, Ipswitch, MA), and transformed into a chemically competent E. coli MFDpir strain,
14

which are auxotrophic for diaminopimelic acid (DAP) [79]. The bacteria was plated on LB plates
+ DAP. These E. coli MFDpir were then mated with either Y. pseudotuberculosis or Y. pestis,
and plated on LB + DAP. The mated cells were collected and plated on LB without DAP (to
prevent growth of E. coli MFDpir) which had the antibiotic kanamycin (Km) added to select for
successful transformations. Transformants were picked and then grown on LB + 10% sucrose
plates were used to ensure double crossover events. Successful transformations were verified
with PCR using the rfaH 500 F & R primers to show the change in product size which correlates
with insertion of the larger KmR gene and the rfaH internal F& R primers (Table 1) to show that
the rfaH gene is removed (Figure 3B). The newly created strains were called Y.
pseudotuberculosis ΔrfaH and Y. pestis ΔrfaH.
The rfaH gene was reinserted via plasmid vector into ΔrfaH mutant strains to create
complemented strains. The rfaH gene and its native promoter from either Y. pseudotuberculosis
or Y. pestis were amplified using rfaH forward and reverse primers which included 200 bp
upstream and downstream of the rfaH gene. The primers designed using Geneious (Biomatter
Inc., Newark, New Jersey) and ordered from Sigma-Aldrich (St. Louis, Missouri) and are shown
in Table 1. The amplified rfaH gene was inserted using restriction enzymes SalI and XbaI (New
England Biolabs, Ipswitch, Maine) into a low copy plasmid, pACYC184 [80]. The plasmid was
then electroporated into the ΔrfaH bacteria. The electroporation involved performing a series of
washes with cold water to make the Y. pseudotuberculosis or Y. pestis strains competent. The
competent bacteria were mixed with 5 µL of plasmid and were added to a 1mm cuvette (Genesee
Scientific, San Diego, California) and placed in a MicroPulser Electroporation Apparatus (BioRad, Hercules, California) and the Ec1 setting used to deliver the shock. Immediately after the
shock, 500 µL of Recovery Media (Lucigen, Middleton, Wisconsin) is added and the bacteria
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were placed on the shaker for 1-2 hours. They are then plated on plates with antibiotics to select
for positive electroporations. The new complement strains created were called Y. pestis rfaH+
and Y. pseudotuberculosis rfaH+.
Lipopolysaccharide isolation and analysis
Bacteria were grown overnight (12-18 hours) at 21°C or 37°C in TB. The culture was
then diluted to be OD 1.0 in 5 mLs. It was then pelleted and the pellet was resupended in 1 x
SDS-buffer (4% β-mercaptoethanol, 4% sodium dodecyl sulfate (SDS), in 0.1 Tris-HCL, pH 6.8
with bromophenol blue). The bacteria were boiled for 15 min and cooled at room temperature for
15 minutes. The samples were treated with proteinase K and incubated at 37°C overnight. Ice
cold Tris saturated phenol is added and then vortexed. The samples were incubated at 65°C for
15 minutes and then diethyl ether is added. The samples are centrifuged and the bottom blue
layer was collected which contained the isolated LPS.
The extracted LPS were run on 4-20% Tru-PAGE Precast Gels (Sigma-Aldrich, St.
Louis, Missouri) at 95 V. The gel was stained using the Pro-Q Emerald 300 Staining kit
following the manufacturer’s protocol (Invitrogen, Carlsbad, California). The stained gel was
visualized using a UV transilluminator.
RNA extraction and gene expression changes
The bacterial RNA was extracted using rBAC RNA Isolation Kit (IBI Scientific, Peosta,
Iowa) following the manufacturer’s instructions. The bacteria used were grown in TB at 21°C
and 37°C for 16 hours to be in stationary phase for extraction. The presence of RNA was verified
by running the RNA out on a bleach agarose gel. Any DNA contamination was then removed
using the Amibon Turbo DNAse Free Kit (ThermoFisher Scientific, Waltham, Maine). The
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concentration of the RNA was checked using a Nanodrop ND-1000 (ThermoFisher Scientific,
Waltham, Maine). cDNA was made from the RNA using a ProtoScript II First Strand Synthesis
Kit (New England Biolabs, Ipswitch, Maine). The concentration of the cDNA was checked on a
Nanodrop and then all samples were diluted to 70 ng/µL and were then used in quantitative PCR
reactions (qPCR).
qPCR primers were designed using Geneious (Biomatter Inc., Newark, New Jersey) and
are listed in Table 2. Primers were ordered from Invitrogen (Carlsbad, California) or SigmaAldrich (St. Louis, Missouri). qPCR 2x Green Master Mix, High ROX (Genesee Scientific, San
Diego, California) was used in 20 uL reactions with 3 µM each of forward and reverse primers
and the reaction was run on a StepOne Real-Time PCR System machine and the data were
analyzed using StepOne Software v2.1 (Applied Biosystems, Carlsbad, California). The two-step
cycling conditions were the following: 95°C for 15 min, followed by 35 cycles of 95°C for 20
seconds then 60°C for 1 min. A melt curve analysis was then performed which included 95°C for
15 seconds followed by 60°C for 1 min. This temperature was increased in increments of 0.3°C
each cycle. The resulting CT values were normalized to a control gene, nlpD, which has been
used as a control gene in other studies [81]. Comparative ΔΔCT values were calculated and used
to show the fold changes as described previously [82].
Antimicrobial chemokine binding assay
The ability of CCL28 to bind to bacteria was tested using a flow cytometric assay
designed in the Erickson and Wilson laboratories. Bacteria were grown up in TB broth at 37°C
overnight. A subculture was started the next morning and grown to mid-logarithmic phase (OD
0.6). 1 mL was removed and centrifuged and resuspended in Phosphate Buffered Saline (PBS)
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with 0.5 g bovine serum albumin added (PBSA). 5 µL of the diluted bacteria was added to 100
uL of PBSA and 10 µL of CCL28 (0.5 µg/µL). The sample was then vortexed and incubated at
room temperature for 30 min. After 30 min the sample was washed in PBSA and then
centrifuged. 5 µL of biotinylated anti-CCL28 (0.5 µg/µL; R&D Systems, Minneapolis,
Minnesota) was added and incubated for 30 min. Another wash is performed and then
Streptavidin-Allophycocyanin (APC; BD Biosciences, San Jose, California) is added and
incubated for 1 hour. After a wash, the samples are run on a BD Accuri C6 Flow Cytometer (BD
Biosciences, San Jose, California) to measure fluorescence of APC.
Killing assays
The ability of CCL28 or polymyxin to kill bacteria was tested using a flow cytometric
assay designed in the Erickson and Wilson laboratories. Bacteria were grown up in TB broth at
37°C overnight. A subculture was started the next day and grown to OD 0.6. The bacteria were
then diluted 1:25 in potassium phosphate buffer (containing 0.2 M KH2PO4 and 0.2 M K2HPO4;
PPB). CCL28 (0.5 µg/µL), polymyxin (10 µg/µL) or BSA (0.01g) were then mixed with the
bacteria. The samples were incubated for 2 hours and then counting beads were added (diluted
1:62500, PolyBead Polystyrene 1µm Microspheres, Polysciences Inc., Warrington,
Pennsylvania). 7 µL of propidium iodide (PI) (Invitrogen, Carlsbad, California) was added
before running the samples on the BD Accuri C6 Flow Cytometer. Percent survival was
calculated by subtracting PI positive cells from the total number of treated bacteria (CCL28 or
polymyxin) divided by PI positive cells from the total number of untreated bacteria (BSA) per
30,000 beads.
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Mouse infections
5 mL of P+ or P- strains of wild-type and ΔrfaH Y. pseudotuberculosis were grown up
overnight at 28°C in TB broth. P- strains were then subcultured in 40 mLs (5 mLs for P+ strains)
of TB broth and grown until OD 1.0. Once the OD reached 1.0, the bacteria were spun down and
resuspended in 1 mL of PBS. The inoculum was then centrifuged and resuspended in 1 mL of
PBS. 100 µL of each strain was infected orally using a tube and ball syringe to either a male or
female BALB/c mouse that was approximately 3 months of age. The mice were separated into
different cages according to the strain of bacteria used to infect. The CFU of the inoculum was
measured by performing serial dilutions of the inoculum and plating 100 µL onto Yersinia
Selective Agar (YSA) plates (which contain bile salts, crystal violet, and irgasan). ~2 x 108
CFU/mL were used to infect for the P+ strains and ~2 x 109 CFU/mL were used for the P- strains.
The mice were fasted for 16 hours before infection and were then given food 2 hours after
infection. The mice were observed for three days and on the third day the mice were sacrificed
and the mesenteric lymph nodes, Peyer’s patches, fecal pellets, spleen, and liver were collected.
These organs were weighed and homogenized in PBS. Serial dilutions were performed and
plated onto YSA plates. Colonies were counted and the CFU/g of each organ was calculated.
Intravenous infections were also performed and the bacteria were prepared in a similar
method except the amount of bacteria used to infect was ~1 x 105 CFU of Y. pseudotuberculosis
P-. The mice were infected retro-orbitally under anesthesia with 100 µL of bacteria. After 3 days
of infection, the mice were sacrificed and the liver and spleen were harvested, homogenized, and
then plated on YSA plates. The colonies were counted and the CFU/g of each organ was
calculated.
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RESULTS
The rfaH gene is deleted from Y. pseudotuberculosis and Y. pestis and complementation is
successful in Y. pseudotuberculosis but not in Y. pestis
To test the function of the rfaH gene in Y. pseudotuberculosis and Y. pestis, the gene was
removed from each bacterial genome and replaced with a kanamycin resistance gene. The rfaH
gene in Y. pseudotuberculosis is 99.8% identical to the rfaH gene in Y. pestis, as shown in Figure
3C. The gene was first deleted from Y. pestis using lambda-red recombination because of its
greater ability to take up DNA via electroporation. After the mutation was made in Y. pestis, the
modified allele (rfaH upstream and downstream regions flanking the kanamycin resistance gene)
was cloned into the suicide plasmid pRE112. The gene deletion strategy and result are shown in
Figure 3A and 3B. The mutations were verified through PCR and gel electrophoresis which
showed an appropriate change in size using primers that flank the rfaH gene and the absence of
the rfaH gene using rfaH internal primers.
In order to show that any change observed in these strains was due to the loss of the rfaH
gene and not any other downstream effects, functional rfaH genes were added back to the
mutants. The rfaH gene was amplified from Y. pseudotuberculosis and Y. pestis using PCR and
inserted into a low copy plasmid, pACYC184, which exists at about 15 copies per cell. The
resulting plasmid was electroporated into the Y. pseudotuberculosis and Y. pestis ΔrfaH strains.
The presence of the plasmid with the rfaH gene insert within the ΔrfaH strains was verified with
PCR (Figure 3B). These complemented strains were named Y. pseudotuberculosis rfaH+ and Y.
pestis rfaH+. As will be discussed below, the Y. pseudotuberculosis rfaH+ strain was able to
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restore or mostly restore the wild-type phenotype. The Y. pestis rfaH+ strain was unable to
complement the phenotypes observed.
Another complementation attempt was performed using a site-specific Tn7 transposon to
insert the rfaH gene back into the Y. pseudotuberculosis and Y. pestis bacterial chromosome
without disrupting any genes [83]. An advantage of this method would be that the rfaH gene
would be present as a single copy as opposed to multiple copies found in the pACYC184
plasmids. The successful insertion of the Tn7 into the bacterial chromosome was verified by
PCR. As will be described below, this complementation strain was unable restore the wild-type
phenotype in either Y. pseudotuberculosis or Y. pestis.
RfaH impacts lipopolysaccharide synthesis in Y. pseudotuberculosis and Y. pestis differently
As RfaH plays a role in the synthesis of the LPS in E. coli and Salmonella, we first
wanted to determine if RfaH influences the synthesis of the LPS in Y. pseudotuberculosis and Y.
pestis. In Yersinia, the composition of the sugars in LPS changes depending on the growth
temperature of the bacteria (Figure 1). The LPS was extracted from cultures grown at two
temperatures, 21°C and 37°C, to determine any changes that occur in the LPS based on
temperature.
While examining the Y. pseudotuberculosis LPS, we found that the core oligosaccharide
of the ΔrfaH mutant is truncated in comparison to the wild-type strain at both temperatures
(Figure 4). The Y. pseudotuberculosis ΔrfaH strain also results in the partial loss of the O-antigen
at 21°C as the band in that region is fainter. Y. pseudotuberculosis does not produce an O-antigen
at 37°C which is observed as an absence of O-antigen bands. When the rfaH gene was placed in
a plasmid and inserted into the Y. pseudotuberculosis ΔrfaH strain creating a complemented
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strain it restores the size of the core and presence of the O-antigen and resembled that of the
wild-type strain.
For comparison, we included LPS from a Y. pseudotuberculosis hldD transposon mutant
(hldD::Tn5) strain. The hldD gene functions to synthesize the first ʟ-ᴅ Heptose I which is
attached to the Kdo residue (see Figure 1 for Y. pseudotuberculosis LPS structure). Therefore, in
the hldD::Tn5 lane the size of the two Kdo residues can be visualized in relation to the full core
(containing 3 ʟ-ᴅ Heptose residues, GlcNAc (N-acetylglucosamine), glucose, and ᴅ-ᴅ Hep or
galactose, depending on the temperature). The truncation observed in the Y. pseudotuberculosis
ΔrfaH mutant is not as extreme as found in the hldD::Tn5, indicating that it likely has lost the
heptose/galactose residue and one of the heptose residues.
In Y. pestis, the core region of strain KM218 was previously shown to be larger when the
bacteria were grown at 25°C rather than at 37°C [84]. These researchers found that this was
correlated with the production of glucose, galactose, 2 ʟᴅ-Hep, ᴅᴅ-Hep, and 2-amino-2deoxyglucose (GlcN) sugars at 25°C rather than the same monosaccharides except galactose at
37°C. In contrast, we found that the core oligosaccharide of Y. pestis KIM6+ is shorter when
grown at 21°C than at 37°C (Figure 4). The rfaH gene is required for production of this longer
form of core oligosaccharide at 37°C, since we saw no difference in the size of the LPS band
when comparing the wild-type and ΔrfaH mutant at 21°C whereas the core appeared shorter in
the ΔrfaH mutant strain at 37°C. At 37°C the Y. pestis ΔrfaH core is likely missing the ᴅ-ᴅ
Heptose/galactose residue and one or two of the ʟ-ᴅ Heptose residues (Figure 1). We attempted
to complement the phenotype of the ∆rfaH mutant of Y. pestis. We transformed the ∆rfaH
mutant with the same plasmid containing the rfaH gene from Y. pseudotuberculosis. This
plasmid failed to complement the wild-type phenotype in Y. pestis. Since the Y. pestis rfaH
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sequence differs by one nucleotide we also created a plasmid containing the Y. pestis version of
this gene. This plasmid also failed to restore the wild-type phenotype. We then attempted
complementation of the mutant by chromosomal insertion of the rfaH gene at the attTn7
insertion site which also failed to complement the phenotype (data not shown). In bacterial
genetic studies, when phenotypes are unable to be complemented, this can be due to additional
mutations in unknown genes. To see if this were happening in the Y. pestis ΔrfaH mutant we remade the mutation in Y. pestis KIM6+ wild-type strain using the pRE112 suicide plasmid. The
same mutant phenotypes were observed in this strain but again, this mutation was not able to be
complemented via expression of the gene from a plasmid.
Genes that function in lipopolysaccharide synthesis are downregulated with loss of rfaH
Since the loss of RfaH caused truncation of the core oligosaccharide as well as loss of Oantigen, we wanted to determine the corresponding changes in gene expression that were
responsible. We isolated RNA from wild-type, ∆rfaH mutant, and the complemented strains of
both Y. pseudotuberculosis and Y. pestis, at both 21°C and 37°C. We then measured transcription
of LPS-related genes using qPCR. Genes that function in either O-antigen or core
oligosaccharide synthesis were selected for examination (Table 3). The ddhD gene cluster has an
8-bp ops sequence upstream and contains genes which are annotated to encode O-antigen
synthesis proteins, as shown in Figure 2 (ddhD-wbyK). From this cluster, we selected ddhD,
ddhA, ddhB, ddhC, wbyJ, and wbyK to examine. In addition to these genes, we also measured
transcription of waaQ, waaE, and waaC which are not found in this region. These are separate
genes found in different operons throughout the genome and are predicted to function in core
oligosaccharide synthesis and do not possess an ops sequence. As an internal control, we also
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measured transcription of the dnaE gene, which showed no significant differences in any of the
comparisons we made (Table 4).
As shown in Table 4, at both 21°C and 37°C in Y. pseudotuberculosis (columns 2 and 4)
the genes in the ddhD gene cluster are significantly downregulated (* indicates p < 0.05). The
downregulation increases in genes furthest from the promoter (wbyI and wbyK). The genes which
function in the synthesis of the core (waaQ, waaE, and waaC) were downregulated in the ΔrfaH
mutant even though they do not have a detectable ops sequence upstream. These results correlate
with truncation we observed in the core region and the lack of O-antigen in the LPS isolated
from the both the O-antigen and core regions of the LPS in Y. pseudotuberculosis ΔrfaH mutant
(Figure 4).
We also measured transcription of the same genes in Y. pestis at both temperatures in
wild-type and ΔrfaH mutant bacteria (Table 4). When grown at 37°C the only gene that appeared
to be downregulated was ddhD (column 5). However, at 21°C we found downregulation in all of
the ddhD gene cluster genes (ddhD, ddhA, ddhB, ddhC, wbyI, and wbyK). The core transferase
genes (waaQ and waaE) were not downregulated in Y. pestis at either temperature, and the waaC
gene was only affected by the ΔrfaH mutation at 21°C. Thus, we could not associate reduced
transcription of any of the LPS-related genes we tested in Y. pestis at 37°C with the altered core
length observed in Figure 4.
We also calculated the fold change in expression of each gene in wild-type bacteria when
grown at 21°C compared to the expression at 37°C (Table 5). There were only a few genes that
are significantly downregulated at 37°C as compared to 37°C in the wild-type Y.
pseudotuberculosis: ddhD, ddhA, wbyI, and wbyK (column 2). This reduction in transcription of
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these genes may contribute to the loss of O-antigen production at 37°C. In Y. pestis wild-type
only ddhD and wbyK are downregulated in 21°C as compared to 37°C (column 3). There are no
differences in the expression of the LPS synthesis genes in the Y. pestis ΔrfaH strain when grown
at the different temperatures (column 5). This indicates that the RfaH protein is not active at
37°C or that the genes are transcribed hardly at all so that the differences are not detected.
RfaH is necessary for protection against antimicrobial chemokine binding in Y.
pesudotuberculosis but not Y. pestis
As the LPS plays an important role in the defense against host antimicrobial peptides
[55], Y. pseudotuberculosis and Y. pestis strains were examined to see if the loss of rfaH
decreased resistance of the bacteria to two peptides. We first measured the impact of rfaH
deletion on binding to the antimicrobial chemokine CCL28 using flow cytometry. As shown in
Figure 5A the Y. pseudotuberculosis wild-type displays low binding by CCL28 but when the
rfaH gene is deleted there is a significant increase in binding. CCL28 requires an unknown
surface protein for binding to the surface of Y. pseudotuberculosis. These results show that the
rfaH deletion truncates the LPS barrier so that CCL28 has easier access to bind to the bacteria.
When the rfaH gene is reinserted into the into the Y. pseudotuberculosis ΔrfaH there is a
significant reduction of binding by CCL28, although it does not completely restore the wild-type
binding levels. The Y. pseudotuberculosis hldD::Tn5 strain, a positive control which has a
truncation to the Kdo residues in the LPS, displays a similar level of high binding. We observed
in the gel analysis that the hldD::Tn5 strain LPS is much shorter than the ΔrfaH strain (Figure 4).
As there is not a significant change in binding between the two strains, it appears that there is a
certain threshold where more truncation in the LPS does not matter.
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We also sought to measure the effect of rfaH mutation on binding to Y. pestis. Figure 5B
shows that binding that the wild-type Y. pestis normally displays a 35% binding by CCL28. This
binding does not change significantly in the Y. pestis ΔrfaH or the Y. pestis rfaH+ strains. The
results show that when the LPS is truncated at 37°C in Y. pseudotuberculosis there is an increase
in binding by CCL28 but it does not change binding in Y. pestis, which is unexpected. It is
possible that Y. pestis has some other defenses apart from the LPS which protect against host
defense peptides when grown at 37°C which are not found in Y. pseudotuberculosis.
Loss of rfaH increases susceptibility of Y. pseudotuberculosis to killing by antimicrobial
peptides and chemokines but does not affect Y. pestis
Since a rfaH mutation increased the ability of CCL28 to bind to the surface of the
bacteria, we reasoned that this would also increase susceptibility to antimicrobial chemokines.
To test this, we measured bacterial survival in the presence of CCL28 or polymyxin B in low
osmolarity conditions using flow cytometry. The Y. pseudotuberculosis wild-type strain was
largely unaffected when incubated with CCL28, around 80% percent survival (Figure 6A). In the
Y. pseudotuberculosis ΔrfaH strain, the percent survival drops significantly to 55%, indicating
that the bacteria had become more susceptible to killing by CCL28. The Y. pseudotuberculosis
rfaH+ strain has restored the percent survival values to wild-type levels. The effect of a rfaH
mutation in Y. pestis was different, however. Figure 6B shows that Y. pestis wild-type has an
80% percent survival, similar to that of the Y. pseudotuberculosis wild-type. There is a slight
decrease in the percent survival of the Y. pestis ΔrfaH strain but it is not significant. These results
support the results of the binding assay for Y. pestis as they both show no change in binding or
killing by CCL28.
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Susceptibility to polymyxin was also affected by rfaH mutation. Y. pseudotuberculosis is
relatively resistant to polymyxin at 37°C. As shown in Figure 7, Y. pseudotuberculosis ΔrfaH
strain shows a dramatic decrease in percent survival as compared to the wild-type (Figure 7A).
The complemented strain showed similar survival to the wild-type strain. In contrast, Y. pestis is
very sensitive to polymyxin at 37°C (Figure 7B). There was a slight decrease in survival in the Y.
pestis rfaH mutant strain but the difference was not statistically significant under these
conditions.
RfaH does not affect the ability of Y. pseudotuberculosis to persist in in vivo oral and intravenous
mouse infections
The truncated LPS and increased susceptibility to antimicrobial peptides and chemokines
indicate that the Y. pseudotuberculosis ΔrfaH strain might not survive as effectively and cause
disease in mice. Previous experiments with pYV negative strains of Y. pseudotuberculosis have
shown that an rfaH transposon mutant could not persist as long as the wild-type in mouse liver or
spleen following an intravenous infection [18]. Another transposon mutagenesis experiment with
Y. pseudotuberculosis containing pYV virulence plasmid showed in an orogastric infection that
O-antigen synthesis gene mutations (ddhC) caused attenuation in the bacteria [85]. We first
compared the ability of Y. pseudotuberculosis wild-type and ΔrfaH cells that carry the pYV
virulence plasmid (P+) to colonize after oral infection. After three days the mesenteric lymph
nodes, Peyer’s patches, spleen, liver, and fecal pellets were collected and the bacterial loads were
determined. As shown in Figure 8A there was there was no significant difference in survival of
Y. pseudotuberculosis wild-type P+ and Y. pseudotuberculosis ΔrfaH P+. Given this unexpected
result, we reasoned that the effect of rfaH on bacterial survival in vivo might only be apparent in
strains lacking the pYV virulence plasmid (P-). We performed similar oral infections (109 CFU)
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in mice using plasmid-cured wild type and rfaH mutant strains. Similar to the P+ strains, there
were no significant differences in bacterial numbers in any organ between the ΔrfaH and wildtype strains (Figure 8B). These results clearly indicate that rfaH is not required for virulence of
Y. pseudotuberculosis strain IP32953 via oral infection.
The lack of rfaH function may have different impacts on bacterial survival depending on
the route of infection. Previous studies have also suggested that transposon insertion mutations in
rfaH may result in reduced ability to colonize via intravenous infection. To investigate this
possibility, we infected groups of mice via intravenous retro-orbital infections with Y.
pseudotuberculosis wild-type P- or Y. pseudotuberculosis ΔrfaH P-. The bacterial loads in the
liver and spleens of these mice were measured following three days of infection (Figure 8C).
Similar to the oral infection results, survival of the rfaH mutant was not decreased compared to
wild-type bacteria in any of the organs. These data shows that although a rfaH deletion alters
LPS structure and increases susceptibility to antimicrobial peptides, these changes do not affect
virulence via the oral or intravenous route in strains that contain the pYV virulence plasmid and
in strains that do not.
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DISCUSSION
The rfaH gene was identified in a transposon mutagenesis screen for mutants of Y.
pseudotuberculosis with increased susceptibility to antimicrobial chemokine binding. This
mutagenesis used Y. pseudotuberculosis strain IP32953 and tested the resistance of each mutant
to binding by CCL28 [55]. Transposon mutagenesis in mice also showed that Y.
pseudotuberculosis YPIII P- rfaH mutants had decreased persistence in BALB/c mice after a coinfection with 20,000 transposon mutants in an intravenous infection for three days [18]. As
RfaH has been identified in E. coli and Salmonella to function as a transcriptional antiterminator
in the synthesis of the LPS, it was selected for further study. Our hypothesis was that RfaH
performs a similar regulatory role in the synthesis of the LPS in two important human pathogens,
Y. pseudotuberculosis and Y. pestis and that these changes would be important for bacterial
survival in vivo.
We showed using SDS-PAGE gel analysis that loss of the rfaH results in no detectable
O-antigen production in Y. pseudotuberculosis. Additionally, the core oligosaccharide of Y.
pseudotuberculosis and Y. pestis are truncated in the ΔrfaH strains, except when the Y. pestis is
grown at 21°C. The core oligosaccharide of the Y. pestis wild-type is much shorter when grown
at 21°C than 37°C. Other studies have shown that the core region in some strains of Y. pestis
(such as in the KM218 strain) is larger when grown at 25°C than 37°C [84]. However, it has
been found that there are structural differences between the LPS in different strains of Y. pestis
whether they are from Eurasia or the Americas [86]. At 21°C it is possible that the KIM6+ strain
does not produce the terminal ᴅ-ᴅ Heptose or galactose sugar which results in a shorter structure.
There might also be changes in phosphorylation, aminoarabinose addition, or other modifications
of the residues. In order to know the exact effect that RfaH has on the LPS structure and why
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there are differences in the wild-type LPS in Y. pestis, it would be important to determine the
structure of the Y. pestis KIM6+ LPS, which has not been done previously. The LPS structure of
several strains of Y. pestis and Y. pseudotuberculosis has been determined by using highresolution electrospray ionization mass spectrometry (ESI MS) [87]. The researchers discovered
that the LPS from Y. pestis KM260 could have up to two 4-amino-4-dioxy-ʟ-arabinose, up to
three phosphate groups, and substitution of several sugars. By extracting the LPS from Y. pestis
wild-type at 21°C and 37°C and performing ESI MS we would be able to identify what changes
are occurring which cause this reduction in size.
Complementation with the rfaH gene in the pACYC184 plasmid was able to restore the
wild-type phenotype in the Y. pseudotuberculosis ΔrfaH strain. There is still a band in these Y.
pseudotuberculosis rfaH+ lanes that is the same size as the core in the ΔrfaH strains indicating
that there might not be complete complementation, and some truncated LPS are still being
synthesized. This intermediate phenotype was also observed in chemokine binding and
polymyxin susceptibility experiments. When the rfaH gene was added to the Y. pestis ΔrfaH
strain it did not detectably alter any of the phenotypes we measured. This could be due to the fact
that perhaps RfaH functions slightly differently in these two stains, or that in Y. pestis the
multiple copies of the rfaH gene is detrimental. It is also possible that secondary, non-target
mutations arise extremely quickly in the Y. pestis ΔrfaH strain that prevent restoration of RfaH
function. A separate complementation strategy was attempted using a Tn7 transposon to insert
the rfaH gene into the bacterial chromosome in the ΔrfaH strains. The benefits of this type of
complementation would be that there is a single copy in the chromosome and there should not be
overexpression of the rfaH gene. However, despite successful insertion of the gene, this was also
unable to complement the truncation LPS in the Y. pestis ΔrfaH (data not shown). After multiple
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attempts via different methods it remains unclear why complementation the rfaH gene in Y.
pestis has not been successful.
We identified specific genes involved in LPS synthesis that were downregulated in the
absence of RfaH which could cause of the alteration of the LPS. Several genes within the ddhD
gene cluster were shown to be downregulated in the ΔrfaH strains and they are annotated as
functioning in the synthesis of the sugars of the O-antigen [9]. This was an expected result since
we were able to identify a clear ops sequence upstream of this operon (Figure 2). The pattern of
downregulation of these genes is consistent with other published studies and the mechanism of
action of the RfaH protein [57, 88]. As the RNA polymerase progresses down the operon during
transcription, it is more likely to prematurely release, causing polarity in ΔrfaH. While all of the
genes exhibit downregulation, the genes wbyI and wbyK which are located furthest from the
promoter exhibit more drastic reduction of expression as compared to the genes in the beginning
of the cluster.
Several genes we examined (waaQ, waaE, and waaC) do not have an ops sequence
upstream and yet were downregulated in the Y. pseudotuberculosis ΔrfaH strain. In Salmonella,
the waa genes occur together in an operon and have an ops sequence upstream and are regulated
by RfaH [76]. Nagy et al. [76] conducted a genome-wide expression experiment to identify all
the genes in Salmonella whose expression is altered by loss of RfaH. They found numerous
changes, despite the presence of only two ops sequences in the genome, including altered
expression of non-LPS related virulence genes. They also showed that these other gene
expression changes were an indirect effect of the LPS truncation in the rfaH mutant. The
downregulation observed in the core genes in Y. pseudotuberculosis might also be an indirect
effect of loss of ddh gene expression. To examine this, individual ddh gene deletions could be
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made in the Y. pseudotuberculosis wild-type strain and expression of the waaQ, waaE, and waaC
genes would be analyzed to see if they are reduced in response to the absence of the O-antigen
genes. It is also possible that a modified ops sequence exists upstream of the waa genes that
remains undetected.
It is interesting that although Y. pestis does not produce an O-antigen it still retains the
ddhD gene cluster. The five genes in this cluster have been inactivated in Y. pestis are ddhB,
wbyI, wzy, gmd, and fcl [9]. We observed that the transcription of these genes is regulated by the
RfaH at 21°C in Y. pestis. However, transcription of the O-antigen or core synthesis genes was
not affected by the loss of RfaH in Y. pestis at 37°C. This is confusing because LPS gel analysis
showed truncation in the core region of the LPS at 37°C but not 21°C. As shown in Figure 1,
there are many other genes that function in the synthesis of the core such as waaA and waaF
which were not chosen for examination in this study. The synthesis of the entire LPS molecule is
a complex process involving many proteins which all are essential to forming the completed
structure. If one of these genes not examined was downregulated by the loss of rfaH it may be
the cause of the truncation of the LPS seen at 37°C. Further experimentation would involve
testing each of these genes for expression changes to see if they are causing the truncation
observed. Another possible explanation is that there are some post-transcriptional functions that
are affected by the loss of the rfaH gene. RfaH has been shown to also activate translation of
certain genes by undergoing conformational changes and interacting with the ribosome [89].
Although transcription might not be influenced, the truncation observed in the LPS might be
from the lack of translation initiation by RfaH. This could be tested by measuring the
concentration of the LPS synthesis proteins in the Y. pestis wild-type and ΔrfaH strains by
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Western Blot analysis. If the LPS synthesis proteins were less concentrated in the ΔrfaH strain it
could indicate that translation might be affected.
We calculated the fold changes between each LPS synthesis gene when grown at either
21°C or 37°C to see if there was an effect of temperature on the activity of RfaH. There was a
fairly uniform, albeit small, decrease in expression of the ddh cluster of O-antigen genes at 37°C
compared to 21°C. There was no consistent change in expression of these genes in Y. pestis
according to temperature. Additionally, in the rfaH mutants, there was also no clear pattern of
temperature-dependent expression, which could be due to extremely low transcript accumulation
in the absence of RfaH.
One of the functions of the LPS is to provide resistance against host defenses including
complement and antimicrobial peptides. When the LPS is truncated it allows for antimicrobial
peptides to more easily reach the bacterial membranes and exert their effect. Studies have shown
previously that truncation in the core region of the LPS in Burkholderia cenocepacia results in
increased susceptibility by antimicrobial peptides [34]. We found that when the LPS is truncated
in Y. pseudotuberculosis at 37° C it dramatically increases the ability of polymyxin B to kill the
bacteria. However the same concentration of polymyxin B used completely killed all the strains
of Y. pestis regardless of the presence of rfaH. It has been shown that Y. pestis is more resistant
to polymyxin B at 21°C than 37°C [31]. This due to higher outer membrane permeability which
results from acyl chain fluidity. The difference between susceptibility between Y.
pseudotuberculosis and Y. pestis is that Y. pseudotuberculosis contains more complex fatty acid
chains and Y. pestis contains saturated fatty acids. While Y. pestis might reduce the number of
acyl chains to avoid recognition by the immune system, it appears to increase its susceptibility to
host defense peptides.
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We observed similar trends with binding and killing by the antimicrobial chemokine,
CCL28. In Y. pseudotuberculosis we see that both binding and killing by CCL28 are increased in
the ΔrfaH strains. In Y. pestis we see no change in the ability of CCL28 to bind to or kill the
bacteria in the ΔrfaH strains. The results are consistent for both experiments because if there was
no increase in binding, we would not expect to see a change in killing by CCL28. The lifestyle of
Y. pestis differs from that of Y. pseudotuberculosis in that it must be able to change expression of
its genes to successfully survive in a flea vector and then a human host. Perhaps some features Y.
pestis expresses at 37°C provide additional protection against host peptides that Y.
pseudotuberculosis does not. Such defenses could include the formation of capsule or the Pla
protease by Y. pestis (carried on plasmids pPCP1 and pMT1), which are not found in Y.
pseudotuberculosis [24].
After testing in vitro resistance of the ΔrfaH strains in Y. pseudotuberculosis and finding
that they become more susceptible, we expected that they would not survive as well in an in vivo
infection. We examined the survival of the Y. pseudotuberculosis strains in an in vivo mouse
infections. We performed two types of infections: oral and intravenous which both showed no
significant changes in survival between the wild-type and the ΔrfaH strains. Other mouse
infections in E. coli and Salmonella have shown that the rfaH mutant strains become attenuated
[74, 76]. Another study showed that in a Y. pseudotuberculosis P- intravenous transposon
mutagenesis infection in an rfaH mutant did not persist as long in the liver or spleen as the wildtype [18]. In these studies, the bacteria were usually co-infected in mice with the wild-type and
rfaH mutant bacteria together, or in pools with 20,000 mutants infecting at once. In the present
study, only single strain infections were performed and it is possible that competition studies
would give a more sensitive measure of the defects caused by rfaH mutation. It could also be
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possible that when rfaH mutants infect on their own (with altered LPS) they do not invoke as
strong of an immune response, but when mixed with other bacteria that do trigger a stronger
inflammatory response, they are preferentially removed. Our strain of Y. pseudotuberculosis is
also different than the strain used in the previously published transposon mutagenesis study.
Further experimentation with a co-infections with our strains might help to distinguish between
these possibilities
While Y. pseudotuberculosis uses the virulence plasmid pYV and Yops proteins to
efficiently establish infection in many organs, other studies have shown that the YPIII P- strains
can also colonize the mesenteric lymph nodes, liver, and spleen [19]. However, we found that the
rfaH gene has no effect on persistence in either plasmid carrying or plasmid absent strains of Y.
pseudotuberculosis. This indicates that rfaH does not play a role in helping the plasmid deficient
bacteria to reach and persist in any of the organs tested because there was still no difference
between the wild-type and ΔrfaH strains.
Overall our research has helped to identify the role the rfaH gene plays in the synthesis of
the LPS in Y. pseudotuberculosis and Y. pestis. This is important information because rfaH
deficient Salmonella strains have been explored as possible vaccine candidates against more
virulent forms [76]. While our initial results show that there is no attenuation in single infection
rfaH deficient Y. pseudotuberculosis this research is only in the beginning stages. Additional
experiments might demonstrate ways that these rfaH deficient strains can potentially be used as
vaccines for Y. pseudotuberculosis. Our work with antimicrobial chemokines helps to increase
our knowledge of these important proteins and how they interact with and kill bacteria based on
the length of the LPS. Antibiotic resistance is on the rise in many human pathogens including
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methicillin-resistant Staphylococcus aureus (MRSA). Antimicrobial chemokines might prove to
be an effective alternative method that could be used to treat antibiotic resistant strains.
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TABLES AND FIGURES
Table 1. Primers used in the rfaH gene deletions and rfaH complementation plasmids.
rfaH 500 F SacI
rfaH 500 R KpnI
rfaH F
rfaH R
rfaH internal F
rfaH internal R

5'- GCC GAG CTC GCC AAT AAT TTA CCA ACA TCT CGC-3'
5'- CCG GGT ACC GCT AAG TAT GCG TCT TGC TAC TAT G-3'
5' - GCC GCG TCG ACT TCG GCG GCT ATG GGA TGC G - 3'
5' - CCG CCT CTA GAG TGC AGG TGC GGA TGG CGT A - 3'
5'-GGC TCA AGC TTC CCT TAG GAC ACC TTC ATG GAC- 3'
5'-GCG TGT CTA GAG GCG TTT AGT TTT CGT TAA CTT ATC TGG GC-3'

Table 2. Primers used in qPCR reactions
ddhD F
ddhD R
ddhA F
ddhA R
ddhB F
ddhB R
wbyI F
wbyI R
wbyK F
wbyK R
waaQ F
waaQ R
waaE F
waaE R
rfaC F
rfaC R
dnaE F
dnaE R
nlpD F
nlpD R

5' – TAT TGG GGA ATG CCA GCA GG - 3'
5' – TGG CTC CGG TCC AAG TAC TA - 3'
5'- TCT ACT TGG GAG CAG GAA CC-3'
5'- CAC GCA ACG TAT CCA TTG GC-3'
5'- CGA TGC TGA GGC TAC TCC AGG-3'
5'- ATG AGG GTG AGC ATT GCC AT-3'
5'- GCG GTA CAC TCG GAG TTG TA-3'
5'-TCC AAA AAT CAT AAT CAC TGA CAG GA-3'
5'- TGC GCG TGG TGG TTA TAA GA-3'
5'- ACT AGT GAA TGC CCC TCC AC-3'
5'- AAC GGC ACA CGC TAC TCA AT-3'
5'- CTC GAT ATC ATG CGG CCC AT-3'
5'- CAG CGT CAT TGT CCC CGT AT-3'
5'- AGA GCC ATC GTT AAC GGC AA-3'
5'-CGT GTG GTA CAA CAA CGC AG-3'
5'-ACT TTT ACA ATC CGG CCC GT-3'
5'-TTT CGT CCC GGT CCG TTA CAA- 3’
5'-ACA AGA TTA TGC CGT AGG TCG-3'
5' – TTC TCG TGG GCA ACC TAT CC - 3'
5' – TGC GTT CCC AGC ATA CAC AA - 3'
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Table 3. List of genes selected for examination by qPCR
Function
O-antigen synthesis

Core oligo synthesis
Control

Gene
ddhD
ddhA
ddhB
ddhC
wbyI
wbyK
waaQ
waaE
waaC
dnaE
nlpD

Product
CDP-6-deoxy-delta-3,4-glucoseen reductase
glucose-1-phosphate cytidylyltransferase
CDP-glucose 4,6-dehydratase
CDP-4-keto-6-deoxy-D-glucose-3-dehydratase
putative glycosol transferase
putative mannosyltransferase
predicted waaQ gene, coding for heptosyltransferase III enzyme
predicted waaE gene, coding for glycosyl transferase family 2
lipoplysaccharide heptosyltransferase
DNA polymerase III α subunit
Outer membrane lipoprotein

Table 4. Fold changes in gene expression compared between wild-type and ΔrfaH strains in Y.
pseudotuberculosis (pstb) and Y. pestis at 21°C and 37°C. Results are the average with standard
error of the mean of 3 independent RNA isolations. * = significantly different from 1 (p-value <
0.05).
Gene
ddhD
ddhA
ddhB
ddhC
wbyI
wbyK
waaQ
waaE
waaC
dnaE

ΔrfaH Y. pstb/wildtype Y. pstb 21°C
0.03 ± 0.01
*
0.07 ± 0.02
*
0.12 ± 0.04
*
0.17 ± 0.05
*
0.001 ± 0.0003 *
0.007 ± 0.002 *
0.05 ± 0.01
*
0.05 ± 0.01
*
0.37 ± 0.12
*
1.27 ± 0.40

ΔrfaH Y. pestis/wildtype Y. pestis 21°C
0.10 ± 0.01
*
0.17 ± 0.05
*
0.37 ± 0.09
*
0.23 ± 0.04
*
0.07 ± 0.04
*
0.02 ± 0.003
*
0.60 ± 0.15
0.66 ± 0.24
2.44 ± 0.14
*
0.88 ± 0.5

ΔrfaH Y. pstb/wildtype Y. pstb 37°C
0.02 ± 0.009
*
0.20 ± 0.06
*
0.21 ± 0.08
*
0.24 ± 0.04
*
0.006 ± 0.002
*
0.005 ± 0.002
*
0.03 ± 0.01
*
0.08 ± 0.01
*
0.65 ± 0.07
*
2.29 ± 0.56

ΔrfaH Y. pestis/wildtype Y. pestis 37°C
0.48 ± 0.09
*
0.97 ± 0.22
0.97 ± 0.14
0.69 ± 0.15
0.55 ± 0.29
0.57 ± 0.15
0.92 ± 0.26
1.23 ± 0.23
3.21 ± 2.24
0.80 ± 0.08
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Table 5. Fold changes in gene expression compared between wild-type or ΔrfaH Y.
pseudotuberculosis (pstb) and Y. pestis at 21°C and 37°C. Results are the average with the
standard error of the mean of 3 independent RNA isolations. * = significantly different from 1
(p-value < 0.05).
Gene
ddhD
ddhA
ddhB
ddhC
wbyI
wbyK
waaQ
waaE
waaC
dnaE

wild-type Y. pstb
37°C/ wild-type Y.
pstb 21°C
0.39 ± 0.08
*
0.34 ± 0.05
*
0.52 ± 0.15
0.66 ± 0.15
0.32 ± 0.02
*
0.25 ± 0.03
*
1.00 ± 0.19
1.20 ± 0.42
0.80 ± 0.10
1.34 ± 0.38

ΔrfaH Y. pstb 37°C/
ΔrfaH Y. pstb 21°C
0.27 ± 0.10
1.30 ± 0.43
0.87 ± 0.18
1.09 ± 0.27
2.45 ± 1.48
0.21 ± 0.005
0.77 ± 0.16
1.56 ± 0.36
1.93 ± 0.96
2.65 ± 1.09

*

*

wild-type Y. pestis
37°C/ wild-type Y.
pestis 21°C
0.16 ± 0.02
*
0.58 ± 0.20
1.34 ± 0.61
1.01 ± 0.12
0.73 ± 0.29
0.05 ± 0.02
*
1.94 ± 0.56
1.46 ± 0.39
3.08 ± 1.33
1.02 ± 0.17

ΔrfaH Y. pestis 37°C/
ΔrfaH Y. pestis 21°C
0.78 ± 0.18
3.21 ± 0.81
3.21 ± 0.82
3.85 ± 1.91
6.26 ± 1.36
1.02 ± 0.12
2.87 ± 0.68
3.51 ± 1.46
1.66 ± 0.22
1.50 ±0.57
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A.

B.

Figure 1. The lipopolysaccharide structure and temperature related changes in Y.
pseudotuberculosis and Y. pestis. Genes that function in the synthesis or addition of different
sugars are displayed. A. Putative Yersinia pseudotuberculosis serotype O:1b IP32953
lipopolysaccharide core and O-antigen grown at 21°C. Derived from elucidated structure of Y.
pestis core. B. Putative Yersinia pestis KIM6+ lipopolysaccharide core grown at 37°C. Changes
in structure due to temperature include two Kdo residue instead of a Ko residue at 37°C. The
outer most residue is always a ᴅ-ᴅ Heptose, whereas at 21°C it could be either a ᴅ-ᴅ Heptose or a
galactose. Kdo = 3-Deoxy-ᴅ-manno-oct-2-ulosonic acid; Ko = ᴅ-glycero-ᴅ-talo-oct-2-ulosonic
acid; GlcNAc = N-Acetylglucosamine.

5’- GGCGGTAG -3’
ddhD

ddhA

ddhB

ddhC

prt

wbyH

wzx

wbyI

wbyJ

wzy

wbyK

Figure 2. ddhD gene cluster, whose genes are annotated to function in O-antigen synthesis.
Putative ops sequence indicated. Red arrow indicates promoter. There are more genes in this
cluster than are indicated in this figure.
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C.

Figure 3. The rfaH gene is deleted from Y. pseudotuberculosis and Y. pestis. A. Gene deletion
strategy utilizing suicide plasmid pRE112. Kanamycin resistance gene (KmR) with 500 bp
upstream and downstream homologous regions of rfaH gene inserted into pRE112. pRE112 is
transformed into E. coli MFDpir. The E. coli strain is mated with either Y. pseudotuberculosis or
Y. pestis. Homologous recombination switches out rfaH gene from bacterial chromosome and the
pRE112 plasmid is removed by plating on 10% sucrose plates. For details, see Materials and
Methods. B. Evidence of successful rfaH gene deletion. Lanes 3, 5, 9, 11 are the rfaH 500 F & R
primers which show increased product size in ΔrfaH and rfaH+ strains in both Y. pstb and Y.
pestis as compared to the wild-type (Lanes 1 and 7) indicating the KmR gene was inserted. Lanes
2, 6, 8, 12 are the rfaH internal primers which show rfaH gene present in wild-type and rfaH+
complemented strains, but not ΔrfaH (Lanes 4 and 10). C. Comparison between the rfaH gene in
Y. pseudotuberculosis and Y. pestis. They share a 99.8% identify with only one nucleotide
change.
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Δ

Figure 4. RfaH impacts lipopolysaccharide synthesis differently in Y. pseudotuberculosis and Y.
pestis. Y. pseudotuberculosis ΔrfaH displays a truncated core oligosaccharide structure at both
21°C and 37°C compared to the wild-type. The core of Y. pestis ΔrfaH is truncated only at 37°C,
as the core of the wild-type Y. pestis is smaller at 21°C.The complementation of the rfaH gene
(rfaH+) appears successful in Y. pseudotuberculosis strains but not in Y. pestis. hldD::Tn5 strain
is shown as a positive control.
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A.

B.

Figure 5. RfaH provides protection against CCL28 binding in Y. pseudotuberculosis but has no
effect in Y. pestis at 37°C A. CCL28 binding with Y. pseudotuberculosis wild-type, ΔrfaH, and
complement strains (rfaH+). The ability of CCL28 to bind is greatly increased in the ΔrfaH
strain as compared to the wild-type. The complement rfaH+ reduces the binding of CCL28. A
positive control, hldD::Tn5, is shown which displays higher binding by CCL28. B. CCL28
binding with Y. pestis wild-type, ΔrfaH, and complement (rfaH+) strains. There is no significant
difference in binding between the wild-type, ΔrfaH, and complement strains. **** = p-value <
0.0001. ** = p-value < 0.05. These are the results of a single experiment done in triplicate, but
repeat experiments show similar trends.
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A.

B.

Figure 6. Loss of RfaH increases susceptibility of Y. pseudotuberculosis but not Y. pestis to
killing by CCL28 at 37°C. A. Percent survival of Y. pstb wild-type, ΔrfaH, and complement
strains (rfaH+) after 2 hour incubation with CCL28. The ability of CCL28 to kill is significantly
increased in the ΔrfaH strain as compared to the wild-type. The complement rfaH+ reduces the
killing of CCL28, similar to wild-type levels. A positive control, hldD::Tn5, is shown which
displays low percent survival when mixed with CCL28. B. Percent survival of Y. pestis wildtype, ΔrfaH, and complement strains (rfaH+) after incubation with CCL28 for 2 hours. There are
no significant differences in percent survival between the wild-type, rfaH-, and complement
strains. * = p-value <0.05. These are the results of a single experiment done in triplicate, but
repeat experiments show similar trends.
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A.

B.

Figure 7. Loss of rfaH increases susceptibility to polymyxin B in Y. pseudotuberculosis but Y.
pestis displays high sensitivity at 37°C A. Percent survival of Y. pseudotuberculosis wild-type,
ΔrfaH, and complement (rfaH+) strains after 2 hour incubation with polymixin. The ability of
polymyxin to kill is significantly increased in the ΔrfaH strain as compared to the wild-type. The
complement (rfaH+) significantly reduces the killing of polymyxin, but not quite to wild-type
levels. A positive control, hldD::Tn5, is shown which displays low percent survival when mixed
with polymyxin. B. Percent survival of Y. pestis wild-type, ΔrfaH, and complement strains after
incubation with polymixin for 2 hours. There are no significant differences in percent survival
between the wild-type, ΔrfaH, and complement strains. * = p-value < 0.05, ** = p-value < 0.005.
These are the results of a single experiment done in triplicate, but repeat experiments show
similar trends.
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Figure 8. RfaH does not affect persistance of Y. pseudotuberculosis IP32953 in single strain in
vivo mouse infection. A. Oral infection with Y. pseudotuberculosis P+ wild-type and ΔrfaH. All 5
organs examined showed no significant differences between the CFU/g tissue between wild-type
and ΔrfaH strains. Mice were infected with 2 x 108 CFU. N = 4. B. Oral infection with Y.
pseudotuberculosis P- wild-type and ΔrfaH. All 5 organs examined showed no significant
differences in CFU/g tissue between the wild-type and the ΔrfaH strains. Mice were infected
with 2 x 109 CFU. N = 7. C. Intravenous infection with Y. pseudotuberculosis P- wild-type and
ΔrfaH. There was no significant difference between the CFU/g tissue in either organ examined.
Mice were infected with 1 x 105 CFU. N = 4. MLN = mesenteric lymph nodes, PP = Peyer’s
patches, FP = fecal pellets, SPL = spleen, and LIV = liver.
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